Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Govt to hire more...

    Govt to hire more inspectors to curb counterfeit drugs menace

    Written by savita thakur thakur Published On 2016-08-24T15:38:35+05:30  |  Updated On 24 Aug 2016 3:38 PM IST
    Govt to hire more inspectors to curb counterfeit drugs menace

    Mumbai : As part of efforts to strength pharma regulations, the government plans to step up vigilance on sale of spurious drugs by increasing the number of drug inspectors, a senior official said.


    "Despite increased vigilance on counterfeit drugs, nearly 2 per cent of these drugs is sold in the market. Efforts are on to strengthen regulation and increase drug inspectors.


    "Nearly 10,000 pharmaceutical manufacturing facilities across the country are monitored and inspected by national and state regulators," said Sudhansh Pant, Joint Secretary at Department of Pharmaceuticals in Ministry of Chemicals and Fertilisers here.


    There are six lakh pharmacies in the country, and in many cases one inspector takes care of 500-1,000 of these, he said, addressing the annual convention of the Indo-American Chamber of Commerce (IACC).


    "We have both national as well as state regulations and with the expansion of industry size, we have also undertaken larger number of inspection. However, there is no linkage between the USFDA inspection and inspection done by our own regulators."


    Commenting on inspection of facilities of drugmakers in India by the US Food and Drug Administration (USFDA), Pant said the growth of pharma industry has made government proud.


    In the last four years, our pharma exports grew to USD 4.6 billion, whereas 26 warning letters were received by the industry from the USFDA. These warnings are insignificant, but we believe quality of drugs cannot be compromised, he said.


    "The Modi Government has taken up this issue with the US Government and industry is talking with the American health regulator. We hope scenario will improve in the near future," the official added.


    Pant said investment in the sector has grown substantially in the last 4-5 years. However, lesser investment in greenfield units is cause of concern.


    An improvement in ease of doing business has also started yielding results and government's intention is to facilitate faster growth of the key industry, he said.

    Department of Pharmaceuticalsdrug inspectorsGovt to hire more inspectorsgrowth of pharma industryIACCIndo-American Chamber of CommerceMinistry of Chemicals and FertilizersSudhansh PantUS Food and Drug AdministrationUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok